Brca1-deficient pancreatic ductal adenocarcinoma cells are hyper-sensitive to DNA-damaging agents

被引：0

作者：

Hirsch, S. ^{[1
,2
]}

Shakya, R. ^{[2
]}

Szabolcs, M. ^{[2
]}

Hartmann, J-T ^{[1
]}

Ludwig, T. ^{[2
]}

机构：

[1] Univ Klinikum Schleswig Holstein, Kiel, Germany

[2] Columbia Univ, Inst Canc Genet, Dept Pathol & Cell Biol, New York, NY USA

来源：

ONKOLOGIE | 2011年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：57 / 57

页数：1

共 50 条

[21] Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents [J].

Cui, Yuxia ;

Palii, Stela S. ;

Innes, Cynthia L. ;

Paules, Richard S. .

CELL CYCLE, 2014, 13 (22) :3541-3550

[22] Novel ATM/ATR pathway inhibitors sensitize p53-deficient cells to DNA-damaging agents in vitro and in vivo [J].

Kawasumi, M. ;

Sloan, H. ;

Bradner, J. ;

Nghiem, P. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 :S30-S30

[23] CDK1 promotes nascent DNA synthesis and induces resistance of cancer cells to DNA-damaging therapeutic agents [J].

Liao, Hongwei ;

Ji, Fang ;

Geng, Xinwei ;

Xing, Meichun ;

Li, Wen ;

Chen, Zhihua ;

Shen, Huahao ;

Ying, Songmin .

ONCOTARGET, 2017, 8 (53) :90662-90673

[24] EFFECT OF ERCC-1 OVEREXPRESSION ON SENSITIVITY OF CHINESE-HAMSTER OVARY CELLS TO DNA-DAMAGING AGENTS [J].

BRAMSON, J ;

PANASCI, LC .

CANCER RESEARCH, 1993, 53 (14) :3237-3240

[25] Suppression of DNA Polymerase β Activity is Synthetically Lethal in BRCA1-Deficient Cells (vol 16, pg 1339, 2021) [J].

Yuhas, Shelby C. ;

Mishra, Alok ;

DeWeese, Theodore L. ;

Greenberg, Marc M. .

ACS CHEMICAL BIOLOGY, 2022, 17 (02) :492-492

[26] Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells [J].

Tang, Mengfan ;

Chen, Zhen ;

Wang, Chao ;

Feng, Xu ;

Lee, Namsoo ;

Huang, Min ;

Zhang, Huimin ;

Li, Siting ;

Xiong, Yun ;

Chen, Junjie .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (06)

[27] Abrogation of the G(2) Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents [J].

Leijen, Suzanne ;

Beijnen, Jos H. ;

Schellens, Jan H. M. .

CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03) :186-191

[28] Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 [J].

Liu, Q. ;

Zhu, Y. ;

Liu, Y. .

CANCER RESEARCH, 2017, 77

[29] Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 [J].

Yinghua Zhu ;

Yujie Liu ;

Chao Zhang ;

Junjun Chu ;

Yanqing Wu ;

Yudong Li ;

Jieqiong Liu ;

Qian Li ;

Shunying Li ;

Qianfeng Shi ;

Liang Jin ;

Jianli Zhao ;

Dong Yin ;

Sol Efroni ;

Fengxi Su ;

Herui Yao ;

Erwei Song ;

Qiang Liu .

Nature Communications, 9

[30] Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 [J].

Zhu, Yinghua ;

Liu, Yujie ;

Zhang, Chao ;

Chu, Junjun ;

Wu, Yanqing ;

Li, Yudong ;

Liu, Jieqiong ;

Li, Qian ;

Li, Shunying ;

Shi, Qianfeng ;

Jin, Liang ;

Zhao, Jianli ;

Yin, Dong ;

Efroni, Sol ;

Su, Fengxi ;

Yao, Herui ;

Song, Erwei ;

Liu, Qiang .

NATURE COMMUNICATIONS, 2018, 9

← 1 2 3 4 5 →